ArticleAmerican journal of cancer research2022

The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma.

Nai-Jung Chiang et al.PubMed ↗Full text ↗

No numbers read from the abstract.